tiprankstipranks
Trending News
More News >
Impact BioMedical, Inc. (IBO)
:IBO
US Market

Impact BioMedical, Inc. (IBO) Stock Statistics & Valuation Metrics

Compare
62 Followers

Total Valuation

Impact BioMedical, Inc. has a market cap or net worth of ―. The enterprise value is $23.42M.
Market Cap
Enterprise Value$23.42M

Share Statistics

Impact BioMedical, Inc. has 12,085,412 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,085,412
Owned by Insiders11.89%
Owned by Institutions0.15%

Financial Efficiency

Impact BioMedical, Inc.’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -8.00%.
Return on Equity (ROE)-0.24
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-8.00%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee535.40K
Profits Per Employee-5.25M
Employee Count2
Asset Turnover<0.01
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Impact BioMedical, Inc. is -3.88K. Impact BioMedical, Inc.’s PEG ratio is 0.00.
PE Ratio-3.88K
PS Ratio0.00
PB Ratio722.43
Price to Fair Value926.61
Price to FCF-30.48K
Price to Operating Cash Flow-30.48K
PEG Ratio0.00

Income Statement

In the last 12 months, Impact BioMedical, Inc. had revenue of 1.07M and earned -10.50M in profits. Earnings per share was -0.06.
Revenue1.07M
Gross Profit1.07M
Operating Income497.15K
Pretax Income-10.50M
Net Income-10.50M
EBITDA-4.61M
Earnings Per Share (EPS)-0.06

Cash Flow

In the last 12 months, operating cash flow was -2.82M and capital expenditures -408.54K, giving a free cash flow of -3.22M billion.
Operating Cash Flow-2.82M
Free Cash Flow-3.22M
Free Cash Flow per Share-0.27

Dividends & Yields

Impact BioMedical, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta3.51
52-Week Price Change-79.83%
50-Day Moving Average0.52
200-Day Moving Average
Relative Strength Index (RSI)42.88
Average Volume (3m)7.09M

Important Dates

Impact BioMedical, Inc. upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date
Next Earnings Date
Ex-Dividend Date

Financial Position

Impact BioMedical, Inc. as a current ratio of 0.01, with Debt / Equity ratio of 2.79%
Current Ratio0.01
Quick Ratio0.01
Debt to Market Cap<0.01
Net Debt to EBITDA-4.36
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Impact BioMedical, Inc. has paid -59.80K in taxes.
Income Tax-59.80K
Effective Tax Rate-0.08

Enterprise Valuation

Impact BioMedical, Inc. EV to EBITDA ratio is -11.96K, with an EV/FCF ratio of -10.88K.
EV to Sales547.95K
EV to EBITDA-11.96K
EV to Free Cash Flow-10.88K
EV to Operating Cash Flow-12.22K

Balance Sheet

Impact BioMedical, Inc. has $353.05K in cash and marketable securities with C$2.65M in debt, giving a net cash position of $2.30M billion.
Cash & Marketable Securities$353.05K
Total DebtC$2.65M
Net Cash$2.30M
Net Cash Per Share$0.19
Tangible Book Value Per Share-$0.18

Margins

Gross margin is 0.00%, with operating margin of -6808.00%, and net profit margin of -14102.00%.
Gross Margin0.00%
Operating Margin-6808.00%
Pretax Margin-15752.00%
Net Profit Margin-14102.00%
EBITDA Margin-4581.33%
EBIT Margin-6808.00%

Analyst Forecast

The average price target for Impact BioMedical, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis